Stimulation Of Anti-Tumor Immunity Using Dendritic Cell/Tumor Cell Fusions And Anti-Cd3/Cd28 - EP2215220
The patent EP2215220 was granted to Beth Israel Deaconess Medical Center on Jan 10, 2018. The application was originally filed on Nov 7, 2008 under application number EP08846621A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".
EP2215220
- Application Number
- EP08846621A
- Filing Date
- Nov 7, 2008
- Status
- No Opposition Filed Within Time Limit
- Nov 16, 2018
- Grant Date
- Jan 10, 2018
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents